Kings Ark Crest

The Kings Ark Mingle™

Decentralized • AI Powered • Universal

Estimated Trade: 0

Active Users: 0

Date: --

Time: --:--:--

Crest

The Kings Ark Mingle™

Decentralized • AI Powered • Universal

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy.

Welcome aboard The Kings Ark™ — where this living chronicle records our rise, our code, and our covenant with creation.

💠

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy.

commentaires · 6 Vues

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels. With a safety profile consistent with existing tr

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels. With a safety profile consistent with existing treatments, experts see it as a breakthrough for patients preferring oral options.

Read Original

The Media Hub: The Kings Ark™
commentaires